Oncogenic KRAS inhibition with ADT-007 primes T cell responses in pancreatic ductal adenocarcinoma

Foote, JB; Mattox, TE; Keeton, AB; Purnachandra, GN; Maxuitenko, Y; Chen, X; Valiyaveettil, J; Buchsbaum, DJ; Piazza, GA; El-Rayes, BF

CANCER RESEARCH, 2023; 83 (7):